Compound Summary

lansoprazole
  Compound Information
 lansoprazole

Compound Name:

lansoprazole

Compound CID:

3883

Synonyms:

lansoprazole

103577-45-3

Prevacid

Bamalite

Monolitum

More...

Iupac Name:

2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole

InChI:

InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)

InChIKey:

MJIHNNLFOKEZEW-UHFFFAOYSA-N

Canonical Smiles:

CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F

Isomeric Smiles:

CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F

Molecular Weight:

369.4

Molecular Formula:

C16H14F3N3O2S

  Compound Structure
 2D Structure:
 3D Structure:
  Computed Properties
 lansoprazole

Molecular Weight:

369.4

Molecular Formula:

C16H14F3N3O2S

Hydrogen Bond Donor Count:

1

Hydrogen Bond Acceptor Count:

8

Rotatable Bond Count:

5

Heavy Atom Count:

25

Complexity:

480

  Synonyms
 lansoprazole

lansoprazole lansoprazole

lansoprazole

103577-45-3

Prevacid

Bamalite

Monolitum

Ogastro

Lansoprazol

Agopton

Limpidex

Lanzor

Opiren

Prevacid SoluTab

Lanzopral

Takepron

Zoton

Lanproton

Lansopep

Lasoprol

Mesactol

Aprazol

Blason

Ketian

Lancid

Lanston

Lanz

AG-1749

(R)-Lansoprazole

Lansoprazolum

Prevacid Iv

AG 1749

Lansox

Lanzo

A-65006

Prevacid 24HR

2-3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylmethylsulfinyl-1H-benzimidazole

CHEBI:6375

Prezal

Pro Ulco

Compraz

Ilsatec

Prosogan

Suprecid

Dakar

Promp

Zoprol

TAK-390MR

2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole

MLS000069705

Lanzol-30

Ogast

MFCD00866873

2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole

2-3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethylsulfinyl-1H-benzimidazole

C16H14F3N3O2S

NCGC00015615-02

SMR000058469

Lansoprazol INN-Spanish

Lansoprazolum INN-Latin

CAS-103577-45-3

DSSTox_CID_3200

MLS-0003247.0001

Prevacid NapraPAC

1H-Benzimidazole, 2-3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinylmethylsulfinyl-

2-(((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1H-benzodimidazole

2-({3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylmethyl}sulfinyl)-1H-benzimidazole

2-3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinylmethylsulfinyl-1H-benzimidazole

DSSTox_RID_76922

DSSTox_GSID_23200

Prevacid I.V.

TAK 390MR

Lansophed

Lanzol

Lanzul

PrevOnco

1H-Benzimidazole, 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-

2-((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methylsulfinyl)-1H-benzodimidazole

2-3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethylsulfinylbenzimidazole

Prevacid (TN)

2-({3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl} sulphinylbenzimidazole;2-({3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl} sulphinylbenzimidazole

1261394-42-6

HSDB 7204

SR-01000000169

A 65006

BRN 4333393

Lanfast

Lapraz

2-{3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylmethylsulfinyl}-1H-benzimidazole

ABT-006

Lansoprazole,(S)

Lansoprazole USAN:USP:INN:BAN

CG-4801

Spectrum_001580

CPD000058469

Prevacid Delayed Release

Opera_ID_1676

Prestwick0_001072

Prestwick1_001072

Prestwick2_001072

Prestwick3_001072

Spectrum2_000444

Spectrum3_000295

Spectrum4_000856

Spectrum5_001521

Dexlansoprazole-13C6

Lopac-L-8533

CHEMBL480

L 8533

cid_3883

Lopac0_000709

SCHEMBL22365

BSPBio_001084

BSPBio_001830

KBioGR_001491

KBioSS_002060

MLS000759405

MLS001074170

MLS001424235

BIDD:GT0006

DivK1c_000920

SPECTRUM1503926

SPBio_000488

SPBio_002992

BPBio1_001194

GTPL7208

DTXSID4023200

BDBM47032

HMS502N22

KBio1_000920

KBio2_002060

KBio2_004628

KBio2_007196

KBio3_001330

Lansoprazole (JP17/USP/INN)

2-(R)-3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylmethylsulfinyl-1H-benzimidazole

2-(S)-3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylmethylsulfinyl-1H-benzimidazole

Levolansoprazole;(-)-Lansoprazole

NINDS_000920

HMS1571G06

HMS1922M04

HMS2052F05

HMS2093M07

HMS2098G06

HMS2234B10

HMS3262M19

HMS3264E12

HMS3269D15

HMS3371E21

HMS3394F05

HMS3413J05

HMS3654J17

HMS3677J05

HMS3715G06

Pharmakon1600-01503926

Pharmakon1600-01504282

ACT03358

BCP22331

BCP34129

EBD14854

Tox21_110184

Tox21_301023

Tox21_500709

BBL029072

BDBM50070208

CCG-39952

CL0035

NSC758638

NSC758710

s1354

STK621169

AKOS005554811

Tox21_110184_1

AC-1233

CS-1847

DB00448

KS-1075

Lansoprazole, >=98% (TLC), powder

LP00709

MCULE-8446262134

NC00411

NSC 758638

NSC-758638

NSC-758710

SB19127

SDCCGSBI-0050687.P004

2-({3-methyl-4-(2,2,2-trifluoroethyl)oxypyridin-2-yl}methyl)sulfinyl-1H-benzimidazole

2-{3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylmethanesulfinyl}-1H-1,3-benzodiazole

IDI1_000920

NCGC00015615-01

NCGC00015615-03

NCGC00015615-04

NCGC00015615-05

NCGC00015615-06

NCGC00015615-07

NCGC00015615-08

NCGC00015615-09

NCGC00015615-10

NCGC00015615-11

NCGC00015615-12

NCGC00015615-14

NCGC00015615-15

NCGC00023826-03

NCGC00023826-04

NCGC00023826-05

NCGC00023826-06

NCGC00023826-07

NCGC00254925-01

NCGC00261394-01

NCGC00381720-13

BL166173

HY-13662

SBI-0050687.P003

AB0005100

AB00052388

EU-0100709

FT-0610894

FT-0670721

FT-0670722

L0233

ST51015040

SW197226-4

D00355

F20528

AB00052388-17

AB00052388_18

AB00052388_19

577L453

A800764

A921066

Q254296

J-007154

SR-01000000169-2

SR-01000000169-6

SR-01000000169-9

BRD-A49172652-001-05-7

BRD-A49172652-001-13-1

F2173-0222

Lansoprazole, British Pharmacopoeia (BP) Reference Standard

Lansoprazole, European Pharmacopoeia (EP) Reference Standard

Lansoprazole, United States Pharmacopeia (USP) Reference Standard

(+)-2-3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinylmethylsulfinyl-1H-benzimidazole

2-({3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethyl}sulfinyl)benzimidazol e

2-({3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylmethane}sulfinyl)-1H-1,3-benzodiazole

2- 3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethylsulfinyl-1H-benzimidazole

2-3-methyl-4-(2,2,2-trifluoro-ethoxy)-2-pyridinylmethyl-sulfinyl1H-benzimidazole

2-3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinylmethylsulfinylbenzimidazole

2-3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl-methylsulfinylbenzimidazole

2-3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethylsulfinyl-1H-benzimidazole

2-3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinylmethylsulfinyl-1H-benzimidazole

2-3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2-ylmethylsulfinylbenzimidazole

2-3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylmethylsulfinyl-1H-benzoimidazole

2-3-methyl-4-2,2,2-tris(fluoranyl)ethoxypyridin-2-ylmethylsulfinyl-1H-benzimidazole

2-3-Methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl-1H-benzimidazole

2-3-methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl-benzimidazole

2-3-methyl-4-(2,2,2-trifluoro-ethoxy)pyridin-2-ylmethanesulfinyl-benzimidazole

2-3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl-methanesulfinyl-1H-benzimidazole

2-3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylmethanesulfinyl-1H-benzimidazole

Lansoprazole for peak identification, European Pharmacopoeia (EP) Reference Standard

1H-Benzimidazole, 2-(S)-3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinylmethylsulfinyl-

2-3-METHYL-4-(2,2,2-TRIFLUORO-ETHOXY)-PYRIDIN-2-YLMETHYLSULFINYL-1H-BENZODIMIDAZOLE

  Experimental Data
 lansoprazole

Species Dose Unit Control(Avg days) Treatment(Avg days) Avg/Med Lifespan Change(%) Control(Max days) Treatment(Max days) Max Lifespan Change(%) Significant Strain Gender PubMed Avg/Med Lifespan Change tab
Caenorhabditis elegans 33.000000000000000 umol/L 10.000000000000000 NS N2 24134630 Inactive
  Experimental Data Visualization
 lansoprazole

  Statistics Data
 lansoprazole

Species Avg/Med Lifespan Change(%) Max Lifespan Change(%) Count Reference Count Data point
Caenorhabditis elegans 10.000000000000000 1 1
  Statistics Data Visualization
 lansoprazole

Home | Browse | Search | Predict | Data | Contact | Help

Copyright © KUST | 滇ICP备16009434号-1 | Dai SX Lab